Where Conmed Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last quarter, Conmed (NYSE:CNMD) received 3 bullish, 3 somewhat bullish, and 1 indifferent analyst rating. The average price target is $129.57, representing an upside from the current price of $120.73. The average price target has increased by 12.08% over the past month.
May 22, 2023 | 4:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Conmed received positive analyst ratings in the last quarter, with an average price target of $129.57, indicating potential upside from the current price of $120.73.
The article mentions that Conmed has received mostly positive analyst ratings in the last quarter, with an average price target of $129.57, which is higher than the current price of $120.73. This indicates that analysts believe the stock has potential for growth in the short term, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100